Operationalising goal setting as an outcome measure: Experience from the PRIME-UK randomised controlled trial
Objective: To select a suitable primary outcome for the evaluation of a multicomponent intervention for people with parkinsonism. Background: The multicomponent PRIME model of care,…Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism
Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD) and vascular parkinsonism (VP)…Analysis of the therapeutic potential of c-Abl inhibition in Multiple System Atrophy
Objective: IkT-148009 is a potent selective inhibitor of non-receptor Abelson Tyrosine Kinases (c-Abl kinases). Our recent analysis of post-mortem brain tissue from patients with Multiple…Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty
Objective: To determine whether MRI and machine learning approaches improve diagnostic accuracy in patients with early-stage parkinsonism compared to clinical criteria Background: Parkinson’s disease (PD)…Digital mobility sub-study in the Parkinson’s Progressive Marker Initiative (PPMI) study.
Objective: To test the feasibility and validity of digital mobility data for enrichment of the prodromal screening and to assess the sensitivity of these measures…A systematic review of Action Observation Therapy for Parkinson’s disease rehabilitation.
Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with AOT. Background: Gait disorders in patients with Parkinson’s disease (PD) are caused…Ataxia, deafness, aphonia associated with ANNA-1/ /”anti-Hu” and LUZP4 antibodies
Objective: To describe the first case of primary mediastinal seminoma resulting in paraneoplastic syndrome (rhombencephalitis) secondary to two antibodies ANNA-1 and LZUP4. Background: Paraneoplastic neurological…Non-motor Symptoms Progression in Parkinson´s Disease. A 4-year Follow-up Study.
Objective: The aim of the present study was to know how Non-motor Symptoms (NMS) change over time in patients with Parkinson´s disease (PD) comparing to…Usability of Parkinson’s KinetiGraph in deep brain stimulation for essential tremor
Objective: To estimate whether Parkinson’s KinetiGraph (PKG) can be useful in quantifying tremor severity in patients with essential tremor (ET) before and after treatment with…Long term effects of Deep Brain Stimulation on Camptocormia in Parkinson’s disease
Objective: Camptocormia (CC) as a syndrome often is a major burden for patients with Parkinson’s Disease (PD). In the absence of response to levodopa (except…
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 186
- Next Page »